| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 112,004 | 94,787 | 85,818 | 215,145 | | Cost of Revenue | 99,090 | 82,510 | 89,357 | 302,917 | | | Gross Profit | 12,914 | 12,277 | (3,539) | (87,772) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,771 | 6,800 | 6,682 | 4,522 | | Non Recurring | (200) | 114 | 205 | 102,494 | | Others |
-
| (119) | 119 | (61,490) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,741 | 5,482 | (10,545) | (133,298) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (189) | 476 | 658 | 2,196 | | Earnings Before Interest And Taxes | 6,154 | 5,958 | (9,887) | (131,102) | | Interest Expense | 1,724 | 1,729 | 1,729 | 1,725 | | Income Before Tax | 4,430 | 4,229 | (11,616) | (132,827) | | Income Tax Expense |
-
|
-
|
-
| (32) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,430 | 4,229 | (11,616) | (132,795) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,430 | 4,229 | (11,616) | (132,795) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,430 | $4,229 | ($11,616) | ($132,795) |
|
0.02% Nasdaq 
0.14 (1.62%) 
Income Statement
